He, B., Wang, Q., Liu, X., Lu, Z., Han, J., Pan, C., . . . Zhou, H. (2020). A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells. Biomedicine & pharmacotherapy, 129, . https://doi.org/10.1016/j.biopha.2020.110390
Chicago-Zitierstil (17. Ausg.)He, Bailin, et al. "A Novel HDAC Inhibitor Chidamide Combined with Imatinib Synergistically Targets Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia Cells." Biomedicine & Pharmacotherapy 129 (2020). https://doi.org/10.1016/j.biopha.2020.110390.
MLA-Zitierstil (9. Ausg.)He, Bailin, et al. "A Novel HDAC Inhibitor Chidamide Combined with Imatinib Synergistically Targets Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia Cells." Biomedicine & Pharmacotherapy, vol. 129, 2020, https://doi.org/10.1016/j.biopha.2020.110390.